SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019619
Filing Date
2017-11-20
Accepted
2017-11-20 16:07:30
Documents
61
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20170930_10q.htm 10-Q 464788
2 EXHIBIT 31.1 ex_100787.htm EX-31.1 9532
3 EXHIBIT 31.2 ex_100788.htm EX-31.2 9660
4 EXHIBIT 32.1 ex_100789.htm EX-32.1 6049
5 EXHIBIT 32.2 ex_100790.htm EX-32.2 6137
  Complete submission text file 0001437749-17-019619.txt   2621825

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20170930.xml EX-101.INS 382089
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20170930.xsd EX-101.SCH 48553
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20170930_cal.xml EX-101.CAL 21554
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20170930_def.xml EX-101.DEF 262897
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20170930_lab.xml EX-101.LAB 179624
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20170930_pre.xml EX-101.PRE 278976
Mailing Address 20 N REAR RD LAKESHORE A6 N0R 1A0
Business Address 20 N REAR RD LAKESHORE A6 N0R 1A0 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 171213819
SIC: 2834 Pharmaceutical Preparations